Ferrari MG, Jimenez-Uribe AP, Wang L, Hoeppner LH, et al. Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target. Oncogene 2023 Dec 23. doi: 10.1038/s41388-023-02925.
PMID: 38135694